IL-38 Evaluation as a Biomarker in Pediatric Asthma

NACompletedINTERVENTIONAL

Enrollment

103

Participants

Timeline

Start Date

August 1, 2020

Primary Completion Date

January 12, 2021

Study Completion Date

April 15, 2021

Conditions

Bronchial Asthma

Interventions

DIAGNOSTIC_TEST

Il-38 serum level

measurement of serum levels of IL-38

Trial Locations (1)

Asmaa Kamal, Cairo

All Listed Sponsors

lead

Cairo University

OTHER

NCT05366491 - IL-38 Evaluation as a Biomarker in Pediatric Asthma | Biotech Hunter | Biotech Hunter